Secondary Logo

Journal Logo

Institutional members access full text with Ovid®

Personalized Dosing Versus Fixed Dosing of Immune Checkpoint Inhibitors

A Cost Analysis Study

Mukherjee, Sarbajit MD1; Ibrahimi, Sami MD1; Machiorlatti, Michael MS2; Roman, Darwin MD3; Saleem, Rabia MD3; Hassan, Ayesha MD3; Baxley, Allison PharmD, BCOP4; Vesely, Sara PhD5; Aljumaily, Raid MD1

doi: 10.1097/MJT.0000000000000774
Letters to the Editor
Buy

1Division of Hematology-Oncology, Department of Internal Medicine, University of Oklahoma, Oklahoma City, Oklahoma

2Department of Biostatistics and Epidemiology, University of Oklahoma, Oklahoma City, Oklahoma

3Department of Internal Medicine, University of Oklahoma, Oklahoma City, Oklahoma

4Department of Clinical Pharmacy Services, University of Oklahoma, Oklahoma City, Oklahoma

5Department of Biostatisctics and Epidemiology, The University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma

The authors have no conflicts of interest to declare.

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.